VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56074804 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010722.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q56074804‏
024 ‎‡a 0000-0002-3561-1288‏ ‎‡2 orcid‏
024 ‎‡a 26638335200‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q56074804‏
100 0 ‎‡a Isabel Marques‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Isabel Marques‏ ‎‡c researcher ORCID: 0000-0002-3561-1288‏ ‎‡9 en‏
400 0 ‎‡a Isabel Marques‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?‏
670 ‎‡a Author's Development and validation of a multiplex-PCR assay for X-linked intellectual disability.‏
670 ‎‡a Author's FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes‏
670 ‎‡a Author's New findings of Neurospora in Europe and comparisons of diversity in temperate climates on continental scales‏
670 ‎‡a Author's Role of the Conserved Cysteine Residues of the 11.5 kDa Subunit in Complex I Catalytic Properties‏
670 ‎‡a Author's Supramolecular organization of the respiratory chain in Neurospora crassa mitochondria‏
670 ‎‡a Author's The 9.8 kDa subunit of complex I, related to bacterial Na(+)-translocating NADH dehydrogenases, is required for enzyme assembly and function in Neurospora crassa.‏
670 ‎‡a Author's Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome‏
670 ‎‡a Author's Unraveling the pathogenesis of ARX polyalanine tract variants using a clinical and molecular interfacing approach‏
670 ‎‡a Author's Usher syndrome and Nebulin-associated myopathy in a single patient due to variants in <i>MYO7A</i> and <i>NEB</i>‏
909 ‎‡a (orcid) 0000000235611288‏ ‎‡9 1‏
909 ‎‡a (scopus) 26638335200‏ ‎‡9 1‏
919 ‎‡a roleoftheconservedcysteineresiduesofthe115kdasubunitincomplex1catalyticproperties‏ ‎‡A Role of the Conserved Cysteine Residues of the 11.5 kDa Subunit in Complex I Catalytic Properties‏ ‎‡9 1‏
919 ‎‡a contractionoffullyexpandedfmr1allelestothenormalrangepredisposinghaplotypeorrareevents‏ ‎‡A Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?‏ ‎‡9 1‏
919 ‎‡a developmentandvalidationofamultiplexpcrassayfor10linkedintellectualdisability‏ ‎‡A Development and validation of a multiplex-PCR assay for X-linked intellectual disability.‏ ‎‡9 1‏
919 ‎‡a fxtasisrareamongportuguesepatientswithmovementdisordersfmr1premutationsmaybeassociatedwithawiderspectrumofphenotypes‏ ‎‡A FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes‏ ‎‡9 1‏
919 ‎‡a newfindingsofneurosporaineuropeandcomparisonsofdiversityintemperateclimatesoncontinentalscales‏ ‎‡A New findings of Neurospora in Europe and comparisons of diversity in temperate climates on continental scales‏ ‎‡9 1‏
919 ‎‡a supramolecularorganizationoftherespiratorychaininneurosporacrassamitochondria‏ ‎‡A Supramolecular organization of the respiratory chain in Neurospora crassa mitochondria‏ ‎‡9 1‏
919 ‎‡a 98kdasubunitofcomplex1relatedtobacterialna+translocatingnadhdehydrogenasesisrequiredforenzymeassemblyandfunctioninneurosporacrassa‏ ‎‡A The 9.8 kDa subunit of complex I, related to bacterial Na(+)-translocating NADH dehydrogenases, is required for enzyme assembly and function in Neurospora crassa.‏ ‎‡9 1‏
919 ‎‡a 2novelpathogenicmid1variantsandgenotypephenotypecorrelationreanalysisin10linkedopitzgbbbsyndrome‏ ‎‡A Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome‏ ‎‡9 1‏
919 ‎‡a unravelingthepathogenesisofarxpolyalaninetractvariantsusingaclinicalandmolecularinterfacingapproach‏ ‎‡A Unraveling the pathogenesis of ARX polyalanine tract variants using a clinical and molecular interfacing approach‏ ‎‡9 1‏
919 ‎‡a ushersyndromeandnebulinassociatedmyopathyinasinglepatientduetovariantsin1myo7a1and1neb1‏ ‎‡A Usher syndrome and Nebulin-associated myopathy in a single patient due to variants in <i>MYO7A</i> and <i>NEB</i>‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000068420416
996 ‎‡2 ISNI|0000000070297605
996 ‎‡2 PTBNP|1294464
996 ‎‡2 PTBNP|885197
996 ‎‡2 PTBNP|267945
996 ‎‡2 PTBNP|1703798
996 ‎‡2 ISNI|000000011079181X
996 ‎‡2 PLWABN|9810631490005606
996 ‎‡2 PTBNP|1605117
996 ‎‡2 PTBNP|1754381
996 ‎‡2 SUDOC|127521372
996 ‎‡2 PTBNP|194335
996 ‎‡2 PTBNP|966340
996 ‎‡2 PTBNP|1304480
996 ‎‡2 ISNI|0000000053124235
996 ‎‡2 BNF|16258004
996 ‎‡2 DNB|1236205847
996 ‎‡2 PTBNP|1040415
996 ‎‡2 PTBNP|1570240
996 ‎‡2 BNF|11580008
996 ‎‡2 SUDOC|159810876
996 ‎‡2 BNF|12417231
996 ‎‡2 PTBNP|1341879
996 ‎‡2 ISNI|0000000068304802
996 ‎‡2 BNF|14495284
996 ‎‡2 DNB|1053183909
996 ‎‡2 PTBNP|1382708
996 ‎‡2 PTBNP|1383313
996 ‎‡2 ISNI|0000000514364128
996 ‎‡2 ISNI|0000000068082410
996 ‎‡2 LC|nr 95034710
996 ‎‡2 SUDOC|191194913
996 ‎‡2 PTBNP|242783
996 ‎‡2 SUDOC|08773902X
996 ‎‡2 BNE|XX6032430
996 ‎‡2 ISNI|0000000428295429
996 ‎‡2 BLBNB|000289515
996 ‎‡2 LC|n 2010012134
996 ‎‡2 PTBNP|974069
996 ‎‡2 ISNI|0000000070612783
996 ‎‡2 ISNI|0000000069914485
996 ‎‡2 PTBNP|1378751
996 ‎‡2 ISNI|0000000121489800
996 ‎‡2 ISNI|0000000068823223
996 ‎‡2 ISNI|0000000070531588
996 ‎‡2 PTBNP|1483854
996 ‎‡2 PTBNP|1184943
996 ‎‡2 PTBNP|1122188
996 ‎‡2 PTBNP|1237069
996 ‎‡2 SUDOC|13020451X
996 ‎‡2 ISNI|0000000070414541
996 ‎‡2 ISNI|0000000069080126
996 ‎‡2 ISNI|0000000070414453
996 ‎‡2 ISNI|0000000069696430
996 ‎‡2 BNC|981058513847306706
996 ‎‡2 DNB|1047965127
996 ‎‡2 SUDOC|033291640
996 ‎‡2 LC|no2022029930
996 ‎‡2 PTBNP|1837479
996 ‎‡2 LC|nr 90017153
996 ‎‡2 PTBNP|231301
996 ‎‡2 LC|n 92034114
996 ‎‡2 ISNI|0000000068091376
996 ‎‡2 BLBNB|000203680
996 ‎‡2 BNE|XX1024338
996 ‎‡2 PTBNP|1430146
996 ‎‡2 ISNI|0000000079768725
996 ‎‡2 NII|DA16297860
996 ‎‡2 PTBNP|1299369
996 ‎‡2 ISNI|0000000111862069
996 ‎‡2 SUDOC|238493202
996 ‎‡2 RERO|A003564137
996 ‎‡2 BNE|XX1180228
996 ‎‡2 LC|n 82135136
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏